Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Daiichi discloses quinolone antibacterial agents

Oct. 11, 1996

Yamanouchi awaits marketing approval for Farom

Oct. 11, 1996

New family of marine natural products discovered

Oct. 11, 1996

Fujisawa antibiotic awaiting MHW approval

Oct. 11, 1996

Procter & Gamble focuses on multifunctional antibacterial agents

Oct. 11, 1996

MC-02331, a new cephalosporin with excellent activity against Gram-positive bacteria

Oct. 11, 1996

Metallo-beta-lactamase inhibitors from SKB

Oct. 11, 1996

Penam sulfones with beta-lactamase-inhibitory activity

Oct. 11, 1996

Antiviral/corticosteroid therapy beneficial for herpes zoster

Oct. 4, 1996

Roche and Gilead Sciences collaborate on the development of neuraminidase inhibitors

Oct. 4, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...